Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1)

NACompletedINTERVENTIONAL
Enrollment

4,000

Participants

Timeline

Start Date

May 22, 2018

Primary Completion Date

July 9, 2020

Study Completion Date

July 9, 2021

Conditions
Carcinoma, Pancreatic Ductal
Interventions
OTHER

Best practices in pancreatic cancer care

All best practices follow the current state of the Dutch guideline on pancreatic cancer and the literature.

Trial Locations (17)

Unknown

Jeroen Bosch Ziekenhuis, 's-Hertogenbosch

Academic Medical Center, Amsterdam

Onze Lieve Vrouwen Gasthuis, Amsterdam

VU Medical Center, Amsterdam

Amphia, Breda

Reinier de Graaf Gasthuis, Delft

Catharina, Eindhoven

Medisch Spectrum Twente, Enschede

University Medical Center Groningen, Groningen

Tjongerschans, Heerenveen

Leiden University Medical Center, Leiden

Maastricht University Medical Center, Maastricht

Radboud University Medical Center, Nijmegen

Erasmus Medical Center, Rotterdam

Maasstad Ziekenhuis, Rotterdam

RAKU (University Medical Center Utrecht and Sint Antonius Ziekenhuis), Utrecht

Isala Klinieken, Zwolle

All Listed Sponsors
collaborator

Dutch Cancer Society

OTHER

collaborator

Comprehensive Cancer Centre The Netherlands

OTHER

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT03513705 - Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1) | Biotech Hunter | Biotech Hunter